Profile data is unavailable for this security.
About the company
Emcure Pharmaceuticals Ltd is an India-based pharmaceutical company. The Company is engaged in developing, manufacturing and marketing a range of pharmaceutical products across several therapeutic areas. It offers a range of products and services under formulations, biologics, and Active Pharmaceutical Ingredients (APIs). It focuses on various key therapeutic areas, such as gynecology, cardiology, anti-infective, diabetes, biologics, mRNA vaccines, and vitamin, minerals and nutrients. It offers products in both, chronic and acute segments. The Company's subsidiary, Gennova Biopharmaceuticals Limited, is a biotechnology company dedicated to developing, producing, and commercializing bio-therapeutics to address life-threatening diseases across various indications. It has developed two platforms: Mammalian and Microbial. Its key APIs consists of S-Amlodipine, Dydrogesterone, Ferric Carboxymaltose, Ferrous Ascorbate, and Eribulin. It operates approximately 13 manufacturing facilities.
- Revenue in INR (TTM)--
- Net income in INR--
- Incorporated1981
- Employees11.15k
- LocationEmcure Pharmaceuticals LtdPlot P-IIIT-BT Park, M.I.D.C., HinjawadiPUNE 411057IndiaIND
- Phone+91 2 035070033
- Fax+91 2 039821444
- Websitehttps://www.emcure.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neuland Laboratories Ltd. | 16.35bn | 3.36bn | 163.85bn | 1.65k | 48.76 | -- | 41.12 | 10.02 | 261.94 | 261.94 | 1,274.50 | -- | -- | -- | -- | 9,922,259.00 | -- | 9.25 | -- | 12.71 | 53.32 | 47.81 | 20.55 | 11.99 | -- | 29.52 | -- | 7.13 | 30.84 | 18.51 | 83.51 | 78.76 | 17.88 | 63.45 |
Sanofi India Ltd | 23.83bn | 4.30bn | 166.05bn | 2.17k | 38.64 | 24.26 | 35.48 | 6.97 | 186.62 | 229.86 | 1,034.61 | 297.26 | 1.67 | 2.73 | 15.60 | 10,960,440.00 | 30.08 | 22.42 | 57.55 | 30.21 | 55.95 | 55.52 | 18.04 | 21.03 | 0.8140 | 435.86 | 0.0313 | 135.49 | 2.92 | 0.573 | -2.85 | 9.64 | -10.34 | 14.73 |
Astrazeneca Pharma India Ltd | 13.88bn | 958.59m | 171.82bn | 940.00 | 179.24 | -- | 154.92 | 12.38 | 38.34 | 38.34 | 555.18 | -- | -- | -- | -- | 14,761,520.00 | -- | 11.78 | -- | 19.62 | 48.51 | 54.64 | 6.91 | 10.27 | -- | 121.25 | -- | 25.62 | 29.17 | 12.21 | 62.66 | 24.29 | -10.46 | -- |
Eris Lifesciences Ltd | 22.62bn | 3.80bn | 185.98bn | 3.08k | 48.96 | -- | 30.47 | 8.22 | 27.91 | 27.91 | 166.06 | -- | -- | -- | -- | 7,344,939.00 | -- | 13.42 | -- | 16.80 | 78.68 | 79.98 | 17.36 | 24.96 | -- | 4.20 | -- | -- | 19.23 | 15.39 | 2.57 | 6.15 | 27.72 | -- |
Jubilant Pharmova Ltd | 68.48bn | 5.53bn | 190.99bn | 995.00 | 34.59 | -- | 20.51 | 2.79 | 34.86 | 34.86 | 432.21 | -- | -- | -- | -- | 68,821,100.00 | -- | 2.96 | -- | 3.55 | 68.13 | 68.47 | 8.01 | 5.13 | -- | 2.34 | -- | 24.73 | 6.70 | -5.95 | 226.43 | -33.08 | 6.48 | 2.13 |
Alembic Pharmaceuticals Ltd | 63.04bn | 6.30bn | 219.16bn | 14.86k | 34.80 | -- | 24.21 | 3.48 | 32.04 | 32.04 | 320.63 | -- | -- | -- | -- | 4,242,974.00 | -- | 10.72 | -- | 14.25 | 73.10 | 65.98 | 9.99 | 12.47 | -- | 12.52 | -- | 28.29 | 10.19 | 9.62 | 80.07 | 1.05 | -15.59 | 14.87 |
Pfizer Ltd | 22.25bn | 6.09bn | 249.64bn | 1.72k | 41.03 | -- | 37.27 | 11.22 | 133.01 | 133.01 | 486.27 | -- | -- | -- | -- | 12,926,610.00 | -- | 14.22 | -- | 17.71 | 65.06 | 61.37 | 27.35 | 24.05 | -- | 43.74 | -- | 82.67 | -9.55 | 1.05 | -11.64 | 5.14 | 33.35 | 9.24 |
Laurus Labs Ltd | 50.54bn | 1.48bn | 251.98bn | 6.01k | 170.39 | -- | 45.59 | 4.99 | 2.74 | 2.74 | 93.40 | -- | -- | -- | -- | 8,413,434.00 | -- | 10.13 | -- | 16.47 | 52.80 | 47.63 | 3.01 | 12.83 | -- | 2.04 | -- | 13.00 | -16.55 | 17.07 | -79.68 | 11.36 | 21.68 | 21.67 |
Natco Pharma Ltd. | 42.21bn | 16.37bn | 265.28bn | 4.02k | 16.21 | -- | 14.54 | 6.28 | 91.37 | 91.37 | 235.68 | -- | -- | -- | -- | 10,510,210.00 | -- | 12.33 | -- | 14.25 | 83.40 | 73.05 | 38.77 | 25.16 | -- | 91.13 | -- | 18.96 | 47.72 | 13.81 | 94.09 | 16.59 | -5.76 | 14.87 |
Concord Biotech Ltd | 10.38bn | 3.13bn | 272.12bn | 1.38k | 86.91 | -- | 74.16 | 26.22 | 29.93 | 29.93 | 99.19 | -- | -- | -- | -- | 7,537,496.00 | -- | -- | -- | -- | 77.16 | -- | 30.18 | -- | -- | 115.93 | -- | -- | 19.20 | -- | 28.33 | -- | -- | -- |
Emcure Pharmaceuticals Ltd | -100.00bn | -100.00bn | 273.91bn | 11.15k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.14 | -- | 13.93 | -- | 59.29 | -- | 7.81 | -- | -- | -- | 0.00 | 11.23 | 7.14 | -6.36 | 21.35 | -5.93 | -- |
Piramal Pharma Ltd | 83.73bn | 277.60m | 288.80bn | 6.72k | 1,038.68 | -- | 37.06 | 3.45 | 0.2107 | 0.2107 | 64.75 | -- | -- | -- | -- | 12,462,350.00 | -- | -- | -- | -- | 64.15 | -- | 0.3315 | -- | -- | 7.12 | -- | -- | 15.39 | -- | 109.56 | -- | -- | -- |
J B Chemicals and Pharmaceuticals Ltd | 35.92bn | 5.87bn | 294.67bn | 5.31k | 51.30 | -- | 40.10 | 8.20 | 36.99 | 36.99 | 226.16 | -- | -- | -- | -- | 6,764,044.00 | -- | 15.77 | -- | 18.89 | 66.27 | 61.18 | 16.34 | 16.06 | -- | 21.04 | -- | 33.08 | 10.63 | 16.22 | 34.84 | 23.36 | 40.15 | 37.42 |
Gland Pharma Ltd | 58.58bn | 7.22bn | 296.63bn | 4.22k | 41.08 | -- | 27.13 | 5.06 | 43.83 | 43.83 | 355.57 | -- | -- | -- | -- | 13,890,770.00 | -- | 13.23 | -- | 14.56 | 61.00 | 55.58 | 12.33 | 22.92 | -- | 34.66 | -- | 7.26 | 56.29 | 22.61 | -1.10 | 11.32 | 24.02 | -- |
Suven Pharmaceuticals Ltd | 9.34bn | 2.40bn | 309.37bn | 1.05k | 128.52 | -- | 104.55 | 33.11 | 9.46 | 9.46 | 36.75 | -- | -- | -- | -- | 8,883,019.00 | -- | 23.17 | -- | 26.20 | 56.59 | 58.85 | 25.73 | 33.21 | -- | 33.74 | -- | 18.63 | -21.56 | 22.71 | -26.99 | 22.41 | -1.83 | -- |
IPCA Laboratories Ltd | 82.12bn | 5.77bn | 363.98bn | 17.34k | 63.10 | -- | 38.36 | 4.43 | 22.74 | 22.74 | 323.71 | -- | -- | -- | -- | 4,737,502.00 | -- | 10.33 | -- | 13.52 | 67.08 | 59.16 | 6.84 | 12.25 | -- | 15.41 | -- | 12.86 | 23.39 | 15.35 | 16.13 | 4.24 | 17.90 | 21.67 |
Holder | Shares | % Held |
---|---|---|
Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Aug 2024 | 1.50m | 0.79% |
Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Aug 2024 | 959.41k | 0.51% |
Mahindra Manulife Investment Management Pvt Ltd.as of 31 Aug 2024 | 695.00k | 0.37% |
Bajaj Finserv Asset Management Ltd.as of 31 Aug 2024 | 537.22k | 0.28% |
ICICI Prudential Life Insurance Co. Ltd. (Invt Port)as of 31 Aug 2024 | 373.62k | 0.20% |
Axis Asset Management Co. Ltd.as of 31 Aug 2024 | 300.83k | 0.16% |
ICICI Prudential Asset Management Co. Ltd.as of 31 Aug 2024 | 297.61k | 0.16% |
Bandhan Asset Management Co. Ltd.as of 31 Aug 2024 | 282.26k | 0.15% |
HDFC Asset Management Co. Ltd. (Invt Mgmt)as of 31 Aug 2024 | 223.11k | 0.12% |
Kotak Mahindra Asset Management Co. Ltd.as of 31 Aug 2024 | 197.88k | 0.11% |